Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Angiodynamics Inc (NQ: ANGO )

7.100 -0.040 (-0.56%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Angiodynamics Inc

< Previous 1 2 3 4 5 6 7 Next >
AngioDynamics to Present at the Needham Virtual Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Wall Street Thinks This Small-Cap Stock Can Double in Value
Analysts are projecting a huge rebound from this beaten-down stock in the next 12 months. 
Via The Motley Fool
Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Preview: AngioDynamics's Earnings
Via Benzinga
Earnings Preview For AngioDynamics
Via Benzinga
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
Why AngioDynamics Shares Are Trading Lower Today
AngioDynamics (NASDAQ: ANGO) shares are trading lower on Thursday after the company reported worse-than-expected Q3 revenue and reduced its 2023 revenue guidance. 
Via Benzinga
US Stocks Open Higher; Dow Jumps 150 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Thursday. Following the market opening Thursday, the Dow traded up 0.48% to 32,874.88 while the NASDAQ rose 0.68%... 
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
From AngioDynamics, Inc.
Via Business Wire
US Stocks Eye Strong Q1 Finish As Futures Point To Higher Open: Jobless Claims, GDP Data In Focus
The positive momentum witnessed in recent sessions could spill over into Thursday as the index futures point to a moderately higher opening. 
Via Benzinga
AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Participate in Three Investor Conferences in March
From AngioDynamics, Inc.
Via Business Wire
American Airlines, Morgan Stanley And 2 Other Stocks Insiders Are Selling
The Nasdaq jumped by around 2% on Wednesday following the Fed’s rate decision. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Is This Under-the-Radar Growth Stock a Buy?
This company is a small player in the steadily growing medtech industry. 
Via The Motley Fool
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance
From AngioDynamics, Inc.
Via Business Wire
Nasdaq, S&P 500 Futures Edgy Ahead Of Data-Heavy Session — Analyst Says Markets In 'Holding Pattern' In Anticipation Of Q4 Results, CPI Print
U.S. stocks look set to open Thursday’s session on a nervous note, potentially reversing the gains from the previous session. 
Via Benzinga
Earnings Scheduled For January 5, 2023
Companies Reporting Before The Bell • Schnitzer Steel Indus (NASDAQ:SCHN) is expected to report quarterly loss at $0.45 per share on revenue of $602.73 million. 
Via Benzinga
Wall Street Thinks This Obscure Growth Stock Could Soar 92% in 2023
As COVID-19 headwinds fade, AngioDynamics' business could rebound. 
Via The Motley Fool
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023
From AngioDynamics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) rose 68% to $0.5500 after surging around 87% on Tuesday. Cosmos Holdings recently posted a Q3 loss of $0.08 per share. 
Via Benzinga
AngioDynamics to Present at the Piper Sandler Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F1885 PE System in Treatment of Pulmonary Embolism
From AngioDynamics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.